CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia - PubMed (original) (raw)
CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia
Takao Hinoi et al. Gastroenterology. 2002 Nov.
Abstract
Background & aims: The intestine-specific caudal-related homeobox transcription factor CDX2 seems to play a key role in intestinal development and differentiation. Inactivation of one Cdx2 allele predisposes mice to develop colon polyps, and loss of CDX2 expression is a feature of some poorly differentiated colon carcinomas in humans. Conversely, aberrant CDX2 expression is often seen in intestinal metaplasias in the stomach and esophagus and in some gastric carcinomas. To better understand CDX2 function, we sought to define CDX2-regulated genes.
Methods: HT-29 colon cancer cells with minimal endogenous CDX2 expression were engineered to express exogenous CDX2, and gene expression changes relative to control cells were assessed using high-density oligonucleotide arrays.
Results: The gene for liver intestine (LI)-cadherin (cadherin 17) was strongly induced by CDX2 in HT-29. In other colorectal cancer lines, endogenous CDX2 and LI-cadherin expression were well correlated. Activation of a ligand-regulated form of CDX2 rapidly induced LI-cadherin gene expression, even in the presence of protein synthesis inhibitor. Analysis of the 5'-flanking region of the LI-cadherin gene defined 2 CDX2 responsive elements, and chromatin immunoprecipitation assays indicate CDX2 binds to the elements. In primary colorectal cancers and intestinal metaplasias in the stomach, CDX2 and LI-cadherin expression were tightly correlated.
Conclusions: CDX2 regulates LI-cadherin gene expression in normal, metaplastic, and neoplastic tissues of the gastrointestinal tract via binding to elements in the 5'-flanking region of the gene. Given the well-established roles of cadherins in morphogenesis and differentiation, LI-cadherin may be a key factor mediating CDX2 function in intestinal cell fate determination.
Similar articles
- CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.
Hinoi T, Gesina G, Akyol A, Kuick R, Hanash S, Giordano TJ, Gruber SB, Fearon ER. Hinoi T, et al. Gastroenterology. 2005 Apr;128(4):946-61. doi: 10.1053/j.gastro.2005.01.003. Gastroenterology. 2005. PMID: 15825077 - CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.
Takakura Y, Hinoi T, Oue N, Sasada T, Kawaguchi Y, Okajima M, Akyol A, Fearon ER, Yasui W, Ohdan H. Takakura Y, et al. Cancer Res. 2010 Sep 1;70(17):6767-78. doi: 10.1158/0008-5472.CAN-09-4701. Epub 2010 Aug 10. Cancer Res. 2010. PMID: 20699370 Free PMC article. - CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, Wong J. Ko S, et al. J Pathol. 2005 Apr;205(5):615-22. doi: 10.1002/path.1741. J Pathol. 2005. PMID: 15732140 - Homeosis and polyposis: a tale from the mouse.
He TC, da Costa LT, Thiagalingam S. He TC, et al. Bioessays. 1997 Jul;19(7):551-5. doi: 10.1002/bies.950190705. Bioessays. 1997. PMID: 9230687 Review. - The role of Cdx proteins in intestinal development and cancer.
Guo RJ, Suh ER, Lynch JP. Guo RJ, et al. Cancer Biol Ther. 2004 Jul;3(7):593-601. doi: 10.4161/cbt.3.7.913. Epub 2004 Jul 9. Cancer Biol Ther. 2004. PMID: 15136761 Review.
Cited by
- Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.
Wu X, Conlin VS, Morampudi V, Ryz NR, Nasser Y, Bhinder G, Bergstrom KS, Yu HB, Waterhouse CC, Buchan AM, Popescu OE, Gibson WT, Waschek JA, Vallance BA, Jacobson K. Wu X, et al. PLoS One. 2015 May 1;10(5):e0125225. doi: 10.1371/journal.pone.0125225. eCollection 2015. PLoS One. 2015. PMID: 25932952 Free PMC article. - Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma.
Chen RY, Cao JJ, Chen J, Yang JP, Liu XB, Zhao GQ, Zhang YF. Chen RY, et al. World J Gastroenterol. 2012 Dec 28;18(48):7251-61. doi: 10.3748/wjg.v18.i48.7251. World J Gastroenterol. 2012. PMID: 23326130 Free PMC article. - Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer.
Naito Y, Oue N, Hinoi T, Sakamoto N, Sentani K, Ohdan H, Yanagihara K, Sasaki H, Yasui W. Naito Y, et al. PLoS One. 2012;7(11):e47545. doi: 10.1371/journal.pone.0047545. Epub 2012 Nov 2. PLoS One. 2012. PMID: 23133598 Free PMC article. - Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA.
Zhang J, Liu QS, Dong WG. Zhang J, et al. Med Oncol. 2011 Jun;28(2):494-501. doi: 10.1007/s12032-010-9489-0. Med Oncol. 2011. PMID: 20393816 - Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells.
Fu Z, Kim J, Vidrich A, Sturgill TW, Cohn SM. Fu Z, et al. Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G632-40. doi: 10.1152/ajpgi.00066.2009. Epub 2009 Aug 20. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19696144 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials